Literature DB >> 1655143

Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin.

D T Martins1, D R Fior, C R Nakaie, C J Lindsey.   

Abstract

1. Kinin analogues bradykinin (BK), T-kinin, Met-Lys-BK, Lys-Lys-BK, Des-Arg9-BK with agonist activity and D-Arg0-Hyp3-Thi5,8-D-Phe7-BK (DAHTDBK) and Arg9-Leu8-BK with antagonist activity were injected into the posterior portion of the fourth cerebral ventricle of unanaesthetized rats implanted with permanent cannulae and arterial pressure was measured directly from the abdominal aorta. 2. The spontaneously hypertensive rats (SHR) were more sensitive than normotensive Wistar rats (NWR) to the pressor effect of BK and other kinin analogues. The SHR did not differ in sensitivity of the pressor response to centrally administered angiotensin II or endothelin-1. 3. Experiments with selective kinin agonists and antagonists revealed that in the SHR, as in the NWR, the receptors which mediated the central pressor response are of the BK2 subtype. 4. Measurements of the pressor activity of kinins with different degrees of susceptibility to degradation, as well as experiments with kininase inhibitors, enalaprilat and CPP-Ala-Ala-Phe-pAB, suggest that the kininase activity in the central nervous system of SHR is reduced in comparison to that of NWR. 5. The SHR also showed increased sensitivity to BK and Lys-Lys-BK, compared with the NWR, when the kinins were injected following the administration of a mixture of the kininase inhibitors, suggesting that mechanisms other than kininase activity may play a role in the increased sensitivity of the SHR to the central pressor action of kinins. 6. An in vivo characterization of the kinin receptors which mediate the central pressor response showed that the interaction with DAHTDBK was reversible and of competitive nature. The pA2 in vivo estimated for the kinin receptors of the SHR was 0.7 logarithm units larger than that obtained in the NWR. 7. The kinin receptors which mediate the central BK pressor effect in the SHR are of the BK2 subtype and are similar to receptors in the NWR. The increased sensitivity to kinins in the SHR may be explained, at least in part, by their decreased kininase activity. At present it is impossible to conclude whether the difference observed in the pA2 represents an increased affinity of the kinin receptors or can be attributed to differences amongst strains in the enzymatic degradation of the antagonist.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655143      PMCID: PMC1908208          DOI: 10.1111/j.1476-5381.1991.tb12341.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Effect of pH on the inhibition of angiotensin converting activity by enalaprilat in the rat perfused mesenteric vascular bed.

Authors:  C J Lindsey; L M Bendhack; A C Paiva
Journal:  J Pharmacol Exp Ther       Date:  1987-10       Impact factor: 4.030

2.  Differential distribution of angiotensin converting enzyme in the anterior and posterior lobe of the rat pituitary.

Authors:  H Y Yang; N H Neff
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

3.  Studies on the pressor responses produced by bradykinin and kallidin.

Authors:  W J Lang; L Pearson
Journal:  Br J Pharmacol Chemother       Date:  1968-02

4.  Assay of kinins by their effects on blood pressure.

Authors:  J Roblero; J W Ryan; J M Stewart
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1973-07

5.  Two bradykinin binding sites with picomolar affinities.

Authors:  D C Manning; R Vavrek; J M Stewart; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-05       Impact factor: 4.030

6.  Behavioural and somatic effects of bradykinin injected into the cerebral ventricles of unanaesthetized rabbits.

Authors:  F G Graeff; I R Pelá; M Roch e Silva
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices.

Authors:  J R McDermott; A M Gibson; J D Turner
Journal:  Biochem Biophys Res Commun       Date:  1987-07-15       Impact factor: 3.575

9.  Participation of neural factor in the pathogenesis of hypertension in the spontaneously hypertensive rat.

Authors:  K Okamoto; S Nosaka; Y Yamori; M Matsumoto
Journal:  Jpn Heart J       Date:  1967-03

10.  A rat brain isozyme of angiotensin-converting enzyme. Unique specificity for amidated peptide substrates.

Authors:  S M Strittmatter; E A Thiele; M S Kapiloff; S H Snyder
Journal:  J Biol Chem       Date:  1985-08-15       Impact factor: 5.157

View more
  7 in total

1.  The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats.

Authors:  C Emanueli; J Chao; D Regoli; L Chao; A Ni; P Madeddu
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats.

Authors:  Frank Cloutier; Hudson de Sousa Buck; Brice Ongali; Réjean Couture
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

Review 3.  Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases.

Authors:  Menglong Wang; Wei Pan; Yao Xu; Jishou Zhang; Jun Wan; Hong Jiang
Journal:  J Inflamm Res       Date:  2022-05-25

4.  Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.

Authors:  Frank Cloutier; Brice Ongali; Maria M Campos; Gaétan Thibault; Witold Neugebauer; Réjean Couture
Journal:  Br J Pharmacol       Date:  2004-04-05       Impact factor: 8.739

5.  Kinin B1 Receptor Promotes Neurogenic Hypertension Through Activation of Centrally Mediated Mechanisms.

Authors:  Srinivas Sriramula; Eric Lazartigues
Journal:  Hypertension       Date:  2017-10-16       Impact factor: 10.190

6.  An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies.

Authors:  Graziela S Ceravolo; Augusto C Montezano; Maria T Jordão; Eliana H Akamine; Tiago J Costa; Ana P Takano; Denise C Fernandes; Maria L Barreto-Chaves; Francisco R Laurindo; Rita C Tostes; Zuleica B Fortes; Renato P Chopard; Rhian M Touyz; Maria Helena C Carvalho
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

7.  Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.

Authors:  Erkan Cure; Medine Cumhur Cure; Hulya Vatansev
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.